Mason Street Advisors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-25,892
| Closed | -$2.2M | – | 1551 |
|
|
2019
Q4 | $2.2M | Buy |
25,892
+834
| +3% | +$55.6K | 0.04% | 544 |
|
|
2019
Q3 | $1.25M | Buy |
25,058
+1,774
| +8% | +$70.8K | 0.03% | 763 |
|
|
2019
Q2 | $849K | Buy |
23,284
+2,172
| +10% | +$70.9K | 0.02% | 916 |
|
|
2019
Q1 | $590K | Buy |
21,112
+697
| +3% | +$16.4K | 0.01% | 1079 |
|
|
2018
Q4 | $391K | Buy |
20,415
+955
| +5% | +$22.2K | 0.01% | 1125 |
|
|
2018
Q3 | $582K | Buy |
19,460
+754
| +4% | +$28.4K | 0.01% | 1054 |
|
|
2018
Q2 | $687K | Buy |
18,706
+816
| +5% | +$26.5K | 0.02% | 977 |
|
|
2018
Q1 | $589K | Buy |
17,890
+1,205
| +7% | +$37.7K | 0.01% | 989 |
|
|
2017
Q4 | $456K | Buy |
16,685
+496
| +3% | +$15.3K | 0.01% | 1060 |
|
|
2017
Q3 | $600K | Sell |
16,189
-1,608
| -9% | -$59.3K | 0.01% | 967 |
|
|
2017
Q2 | $676K | Buy |
17,797
+1,106
| +7% | +$49.3K | 0.02% | 912 |
|
|
2017
Q1 | $816K | Buy |
16,691
+1,489
| +10% | +$67.9K | 0.02% | 873 |
|
|
2016
Q4 | $516K | Buy |
15,202
+880
| +6% | +$31.2K | 0.01% | 960 |
|
|
2016
Q3 | $541K | Buy |
14,322
+722
| +5% | +$27.2K | 0.02% | 918 |
|
|
2016
Q2 | $457K | Buy |
13,600
+1,255
| +10% | +$44.2K | 0.01% | 932 |
|
|
2016
Q1 | $392K | Buy |
12,345
+1,152
| +10% | +$37.6K | 0.01% | 944 |
|
|
2015
Q4 | $418K | Buy |
11,193
+1,356
| +14% | +$51.2K | 0.01% | 918 |
|
|
2015
Q3 | $373K | Buy |
9,837
+688
| +8% | +$24.2K | 0.01% | 926 |
|
|
2015
Q2 | $262K | Buy |
9,149
+455
| +5% | +$12.7K | 0.01% | 1008 |
|
|
2015
Q1 | $244K | Sell |
8,694
-148,432
| -94% | -$4.17M | 0.01% | 1024 |
|
|
2014
Q4 | $4.35M | Buy |
157,126
+303
| +0.2% | +$7.51K | 0.03% | 594 |
|
|
2014
Q3 | $3.5M | Sell |
156,823
-59
| -0% | -$1.5K | 0.03% | 663 |
|
|
2014
Q2 | $4.56M | Buy |
156,882
+275
| +0.2% | +$7.34K | 0.04% | 579 |
|
|
2014
Q1 | $4.45M | Sell |
156,607
-5,560
| -3% | -$184K | 0.04% | 572 |
|
|
2013
Q4 | $6.26M | Buy |
162,167
+978
| +0.6% | +$35K | 0.05% | 413 |
|
|
2013
Q3 | $5.4M | Buy |
161,189
+153,431
| +1,978% | +$4.89M | 0.06% | 339 |
|
|
2013
Q2 | $239K | Buy |
+7,758
| New | +$260K | ﹤0.01% | 1179 |
|
Other funds holding MDCO
Mason Street Advisors's MDCO Position: Q1 2020 in Review
Mason Street Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 25,892 shares — an estimated $2.2M sold.
Mason Street Advisors first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $6.26M in Q4 2013. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Mason Street Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Mason Street Advisors sold 25,892 Medicines Co shares in Q1 2020, an estimated $2.2M.
- Mason Street Advisors first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Mason Street Advisors's Medicines Co position peaked at $6.26M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Mason Street Advisors's 13F filing for Q1 2020, filed 8 May 2020.